ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,595.76
0.75%
US Tech 100
18,933.41
1.01%
Dow Jones
41,096.77
0.58%
Brent Oil
72.125
0.22%
Bitcoin
57,887.73
-0.43%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Adaptive Biotechnologies Corporation (ADPT) Quote

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

Adaptogenics Health Corp
4.30
-0.09
(-2.05%)
Closed September 13 4:00PM
Delayed by 15 minutes
4.2502
-0.0498
(-1.16%)
After Hours: 4:45PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
4.2502
Bid
4.25
Ask
4.98
Volume
681,725
4.24 Day's Range 4.44
2.28 52 Week Range 39.79
Market Cap
626.786M
Previous Close
4.39
Open
4.40
Last Trade
47
@
4.34
Last Trade Time
Financial Volume
$ 2,937,495
VWAP
4.3089
Average Volume (3m)
1,503,236
Shares Outstanding
147,472,201
Dividend Yield
-
PE Ratio
-2.82
Earnings Per Share (EPS)
-1.53
Revenue
170.28M
Net Profit
-225.25M

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.adaptivebiotech.com
Headquarters
Olympia, Washington, USA
Founded
-
Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $4.39. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 39.79.

Adaptive Biotechnologies currently has 147,472,201 shares outstanding. The market capitalization of Adaptive Biotechnologies is $647.40 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -2.82.

Ask ADVFN Intelligence (AI)

ADPT Latest News

More News

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

August 29 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

August 23 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

August 22 2024
Edgar (US Regulatory)

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

August 22 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 01 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 01 2024
Edgar (US Regulatory)

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

SEATTLE, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

August 01 2024
GlobeNewswire Inc.

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

July 11 2024
GlobeNewswire Inc.

Form 8-K - Current report

June 11 2024
Edgar (US Regulatory)

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

May 31 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2898-6.383259911894.545.044.0859516384.60662003CS
41.170237.99350649353.085.042.9913295894.14796875CS
120.480212.73740053053.775.042.2815032363.53034447CS
26-1.9498-31.44838709686.26.862.2815119474.00458068CS
52-34.0198-88.894172981438.2739.792.2812474048.42863854CS
156-37.8498-89.904513064142.171.252.28110897218.62198649CS
2600004.47000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GVVisionary Holdings Inc
$ 4.41
(117.24%)
45.83M
EGIOEdgio Inc
$ 2.11
(115.64%)
106.78M
OBLGOblong Inc
$ 6.42
(89.38%)
33.47M
MNPRMonopar Therapeutics Inc
$ 3.9123
(63.01%)
35.61M
TILInstill Bio Inc
$ 46.48
(56.76%)
1.86M
FULCFulcrum Therapeutics Inc
$ 3.45
(-61.02%)
33.14M
ONCTOncternal Therapeutics Inc
$ 1.69
(-59.33%)
630.54k
MODVModivCare Inc
$ 12.75
(-59.12%)
3.57M
CNEYCN Energy Group Inc
$ 0.6899
(-50.37%)
16.05M
UPCUniverse Pharmaceuticals Inc
$ 1.51
(-50.33%)
19.77M
NVDANVIDIA Corporation
$ 119.14
(1.91%)
351.99M
SQQQProShares UltraPro Short QQQ
$ 8.28
(-2.93%)
175.79M
PEGYPineapple Energy Inc
$ 0.1846
(5.97%)
109.11M
EGIOEdgio Inc
$ 2.11
(115.64%)
106.78M
SMFLSmart for Life Inc
$ 1.20
(41.18%)
84.71M

Discussion

View Full Feed
nwsun nwsun 3 minutes ago
Does anybody know how this possible taxing of unrealized gains will work? And what about unrealized losses. How will they be treated if the government starts taxing unrealized gains? I'm hearing it's coming.
SFLM
PlaceboJeffect PlaceboJeffect 4 minutes ago
Exactly, well put.
PWDY
Nebuchadnezzar Nebuchadnezzar 4 minutes ago
it wont be the last tech stock to announce weaker guidance
ADBE
Nebuchadnezzar Nebuchadnezzar 5 minutes ago
all it needs is a spark ;)
BOTY
satter satter 6 minutes ago
Yet he was arguing and still does that people can't vote for Harris in 9 states because of their state laws saying the deadline passed to remove Biden to change it to Harris. It's the law he says.

There he applied the law. Except him and his maga conspiracy nimwits had it wrong on al
Truth and Transparency Truth and Transparency 7 minutes ago
Mark Smith, Jim Sims and Scott Honan have made us suffer for a decade now. LCP can not inflict any more suffering than they have.

LCP is not responsible for the reduction of long term shareholders shares to 1/10th of what they held. LCP is not responsible for the disastrous SPAC deal
NB
littlejohn littlejohn 10 minutes ago
Francine is spinning out massive rain drops

in the outer bands...

Very, very big rain drops for a

tropical system to be dropping...

Doppler may be underestimating rain that

has fell, still falling, or to fall in this case...
More Belgians More Belgians 11 minutes ago
You overestimate yourself
LWLG
zxjoshuaxz zxjoshuaxz 13 minutes ago
❗️❗️ FULL WSJ ARTICLE BELOW: ❗️❗️

Donald Trump’s allies want once again to try to untie the Gordian knot of the mortgage market: what to do with Fannie Mae and Freddie Mac.

Former Trump administration figures and bankers have been discussing plans on ending U.S. governm
FNMA
zandant zandant 14 minutes ago
Ostrich Ehrlich has buried his empty head in the sand....
IPIX
Threeflight Threeflight 16 minutes ago
LOL. That is rich. I am the biggest believer in a free market, capitalist society as there is.

You are the person supporting a far left marxist in Komrade Harris.
newmedman newmedman 17 minutes ago
It's really not if you've done it numerous times. I forgot to add painting the half walls and ceiling while the other stuff is going on too. The space is so small it should take no time at all and there's already a few coats of marine primer on the walls and ceiling so I could paint a couple fin
Threeflight Threeflight 17 minutes ago
No one with the IQ higher than an amoeba believes that you are on this board for legit reasons. That is trading stocks. On a stock trading message board mind you. I looked back at your history and it seems as if you have no interest in trading at all.

It does seem as if you just
WarMachine WarMachine 21 minutes ago
LMFAO! Only for those that don't comprehend plain English
Some peoples kids FFS

Jammin Java Corp.
447 Broadway, 2nd Floor
Unit 103
New York, NY 10013
Supplemental Information Disclosure for Jammin Java Corp. (the “Company”):
September 9
JAMN
droopyeyes droopyeyes 23 minutes ago
Mods

Do ur job . This moron is vulgar and nasty
More nasty than a porty pot


imo
HIRU
JD400 JD400 23 minutes ago
Drilling Results – How Can You Determine if a Mining Company’s Drill Results are of Low, Medium or High Grade

Drilling results for base metals are typically reported in percentage per tonne (%), while precious metals are reported in grams per tonne (g/t). As an investor, it’s crucial
MUX
fuagf fuagf 23 minutes ago
No missed that one. Are you into animation as all Trump followers are. And as so many other American households are:

[yt]nHUfqFwfmGc[/yt]

https://www.kidsnews.com.au/arts/bluey-becomes-americas-most-watched-tv-show-of-2024/news-story/fdd99884d5c56f73cc8c3fc0e9f490c4
StockItOut StockItOut 25 minutes ago
June 11, 2023: "Xeriant Finalizes Proprietary Manufacturing Process for NEXBOARD™ Green Building Material."

"Xeriant... announces today the successful testing of a proprietary high-volume production process for its environmentally-friendly patent-pending NEXBOARDTM composite co
XERI

Your Recent History

NASDAQ
ADPT
Adaptive Biotechnologies
BIT
P1AJ68
BNP Paribas Issuance
FX
EURHTG
Euro vs HTG
USOTC
TDWRF
Tidewater Renewables (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved